[Skip to Content]

Grants Awarded

Grants Awarded in 2017

  • M. Saeed Sheikh, M.D., Ph.D., Pharmacology, PI
    Higher Education Commission
    The International Research Support Initiative Program, February 2, 2017
  • Richard D. Veenstra, Ph.D., Pharmacology, PI
    Central New York Community Foundation
    Molecular and Ionic Mechanisms for Loperamide Overdose Induced Cardiotoxicity, March 1, 2017
  • Juntao Luo, Ph.D., Pharmacology, PI
    NYS Department of Health
    Structure-Based Nanocarrier Design for Targeted Cabazitaxel Delivery in Advanced Breast Cancer Brain Metastases, January 1, 2017
  • Richard D. Veenstra, Ph.D., Pharmacology, PI
    American Heart Association
    Acetylation and Modulation of the Cardiac L-type Ca2+ Current by HDAC Inhibitors    July 1, 2017 - June 30, 2019
  • Richard J.H. Wojcikiewicz, Ph.D., Pharmacology, PI
    Mechanism of IP3 receptor processing by the ERAD pathway and analysis of the
    IP3 receptor-erlin 1/2 complex-RNF170 axis.    07/01/17-05/31/21
  • Richard J.H. Wojcikiewicz, Ph.D., Pharmacology, PI
    Significance of the novel Bok-IP3 receptor interaction.  08/01/17-04/30/21   
  • M. Saeed Sheikh, M.D., Ph.D., Pharmacology, PI 
    Carol M. Baldwin Breast Cancer Research Fund
    Development of a natural product for breast cancer treatment  12/1/2017 - 11/30/2019                                                                          

Grants Awarded in 2018

  • Juntao Luo, Ph.D., Pharmacology, Co-PI (PI Chan)
    R01, NIH/NHLBI
    Novel anti-HCMV strategies    4/15/2018 - 3/31/2022
  • Juntao Luo, Ph.D. Pharmacology, PI (Luo)
    1 R01 GM130941-01 NIH/NIGMS (PI: Luo, J)
    An innovative hemoperfusion nanotrap for sepsis treatment. 09/20/2018-08/30/2022
  • Ying Huang, M.D., Ph.D., Pharmacology, PI 
    Carol M. Baldwin Breast Cancer Research Fund
    Investigation of RBELIA in human breast cancer 12/1/2018 - 11/30/2020                                                                                    

Grants Awarded in 2019

  • Hong Lu, Ph.D., Pharmacology PI 
    R21, NIH Natl. Inst. Alcohol Abuse
    Liver specific glucocorticoid action in alcoholic liver disease  5/1/2019 - 4/30/2021                        
  • Ying Huang, M.D., Ph.D., Pharmacology PI
    Institutional Bridge Grant 
    MGL in lung cancer signaling and therapeutics 6/1/2019 - 5/31/2020  
  • David Auerbach, Ph.D., Pharmacology PI 
    American Heart Association Career Development Award
    Mechanisms for Arrhythmias and Seizures in Long QT Syndrome 7/1/2018 - 6/30/2021
  • David Auerbach, Ph.D., Pharmacology PI
    Central New York Foundation
    Multi-System Monitoring to Identify Pathological Markers and Mechanisms for Sudden Unexpected Death in Epilepsy 5/1/2019 - 4/30/2020
  • David Auerbach, Ph.D., Pharmacology PI
    American Epilepsy Society Junior Investigator Award (Kevin's Fellow)
    Altered Neuronal Electrical Fundtion in Long QT Syndrome Type 2 7/1/2018 - 6/30/2019
  • Norifumi Urao, M.D., Ph.D., Pharmacology PI
    NIH/NIDDK R01 
    Impact of hematopoietic stem progenitor cell dysfunction on tissue recovery from ischemic injury in metabolic syndrome 8/21/2017 - 7/31/2022 
  • Hong Lu, Ph.D., Pharmacology PI
    R03, NIH Natl. Cancer Inst.
    Liver specific glucocorticoid action in liver cancer  7/1/2019 - 6/30/2021   
  • Laura Szczesniak, M.D., Ph.D. Student, Pharmacology PI (sponsor:  Wojcikiewicz)
    F30, NIH GM
    Mechanism by which Bok binds to IP3Rs and regulates mitochondrial dynamics 8/3/19 - 8/3/22      

Grants Awarded in 2020

  • Juntao Luo, Ph.D., Pharmacology PI
    NY FIRST/Empire State Development Program
    Translational Research for a novel Nanotrap hemoperfusion approach for sepsis treatment.  1/1/2020 - 12/31/2024
  • Juntao Luo, Ph.D., Pharmacology, PI (PI:  Luo, Co-PI:  Cooney)
    SUNY - Upstate Research Pilot Program
    A translational study of a novel nanotrap for sepsis treatment using patient blood samples.
    5/1/2020 - 4/30/2021

 Grants Awarded in 2021

  • Juntao Luo, Ph.D., Pharmacology  PI (PI's:  Juntao Luo, Rinki Agarwal)
    Maureen T. O'Hara TEAL THERE's A CURE and Christine Schoeck Blakely Ovarian Cancer Research Fund
    Establish PDX ovarian cancer models to test novel nanotherapeutics
    1/1/2018 - 12/31/2021